Shell Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Shell Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-65,777	Closed	-$533K	–	1106
2016 Q3	$533K	Buy	+65,777	New	+$559K	0.01%	841
2015 Q4	–	Sell	-90,395	Closed	-$902K	–	962
2015 Q3	$902K	Buy	+90,395	New	+$736K	0.01%	698
2015 Q1	–	Sell	-90,395	Closed	-$1.13M	–	884
2014 Q4	$1.11M	Hold	90,395	–	–	0.02%	670
2014 Q3	$902K	Buy	+90,395	New	+$839K	0.01%	722

Other funds holding ACHN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Shell Asset Management's ACHN Position: Q4 2016 in Review

Shell Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q4 2016, closing a stake of 65,777 shares — an estimated $533K sold.

Shell Asset Management first reported a position in ACHN in Q3 2014 and held it in 4 quarters. The position peaked at $1.11M in Q4 2014. 140 funds tracked by Wall St. Rank hold ACHN as of Q4 2016.

Shell Asset Management reported no remaining Achillion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Shell Asset Management sold 65,777 Achillion Pharmaceuticals shares in Q4 2016, an estimated $533K.
Shell Asset Management first reported a position in Achillion Pharmaceuticals in Q3 2014 and held it in 4 quarters.
Shell Asset Management's Achillion Pharmaceuticals position peaked at $1.11M in Q4 2014.
140 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2016.

Based on Shell Asset Management's 13F filing for Q4 2016, filed 10 Jan 2017.